ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT02291978 | 103:112:treatment, | Individuals who are not able or willing to tolerate the required prolonged stationary position during treatment (can be up to 5 hrs of total table time) | 1 | [
"Individuals",
"who",
"are",
"not",
"able",
"or",
"willing",
"to",
"tolerate",
"the",
"required",
"prolonged",
"stationary",
"position",
"during",
"treatment",
"(",
"can",
"be",
"up",
"to",
"5",
"hrs",
"of",
"total",
"table",
"time",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02287337 | 26:35:treatment | Inability to comply with treatment and follow-up schedule | 1 | [
"Inability",
"to",
"comply",
"with",
"treatment",
"and",
"follow-up",
"schedule"
] | [
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02273375 | 128:137:treatment | Investigators must assure themselves the patients randomized on this trial will be available for complete documentation of the treatment, adverse events, and follow-up | 1 | [
"Investigators",
"must",
"assure",
"themselves",
"the",
"patients",
"randomized",
"on",
"this",
"trial",
"will",
"be",
"available",
"for",
"complete",
"documentation",
"of",
"the",
"treatment",
",",
"adverse",
"events",
",",
"and",
"follow-up"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02273375 | 33:42:treatment | Patients must be accessible for treatment and follow-up | 1 | [
"Patients",
"must",
"be",
"accessible",
"for",
"treatment",
"and",
"follow-up"
] | [
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02273375 | 10:19:treatment, | Protocol treatment is to begin within 2 working days of patient randomization | 1 | [
"Protocol",
"treatment",
"is",
"to",
"begin",
"within",
"2",
"working",
"days",
"of",
"patient",
"randomization"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02272998 | ,35:44:treatment | through 4 months after the end of treatment | 1 | [
"through",
"4",
"months",
"after",
"the",
"end",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02271919 | 15:24:treatment | Interested in treatment that might change smoking behavior | 1 | [
"Interested",
"in",
"treatment",
"that",
"might",
"change",
"smoking",
"behavior"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02268253 | 85:94:treatment | has signed informed consent prior to initiation of any study-specific procedures or treatment | 1 | [
"has",
"signed",
"informed",
"consent",
"prior",
"to",
"initiation",
"of",
"any",
"study-specific",
"procedures",
"or",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02266719 | 36:45:treatment | Patients that are not eligible for treatment with commercially available endografts | 1 | [
"Patients",
"that",
"are",
"not",
"eligible",
"for",
"treatment",
"with",
"commercially",
"available",
"endografts"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02261519 | 179:188:treatment | The identified caregiver should be considered reliable by the Investigator and per the local regulations in providing support to the subject to help ensure compliance with study treatment, study visits and protocol procedures who preferably is also able to provide input helpful for completing study rating scales | 1 | [
"The",
"identified",
"caregiver",
"should",
"be",
"considered",
"reliable",
"by",
"the",
"Investigator",
"and",
"per",
"the",
"local",
"regulations",
"in",
"providing",
"support",
"to",
"the",
"subject",
"to",
"help",
"ensure",
"compliance",
"with",
"study",
"treatment",
",",
"study",
"visits",
"and",
"protocol",
"procedures",
"who",
"preferably",
"is",
"also",
"able",
"to",
"provide",
"input",
"helpful",
"for",
"completing",
"study",
"rating",
"scales"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02259504 | 79:88:treatment | Subject with social, medical, or psychological conditions that interfere with treatment and follow-up evaluation | 1 | [
"Subject",
"with",
"social",
",",
"medical",
",",
"or",
"psychological",
"conditions",
"that",
"interfere",
"with",
"treatment",
"and",
"follow-up",
"evaluation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02236013 | 76:85:treatment | Subject agrees not to participate in another interventional study while on treatment | 1 | [
"Subject",
"agrees",
"not",
"to",
"participate",
"in",
"another",
"interventional",
"study",
"while",
"on",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02234193 | 34:43:treatment | Subject is unable to comply with treatment, home care or follow-up visits | 1 | [
"Subject",
"is",
"unable",
"to",
"comply",
"with",
"treatment",
",",
"home",
"care",
"or",
"follow-up",
"visits"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02208362 | 126:135:treatment | Research participants with any non-malignant intercurrent illness which is either poorly controlled with currently available treatment, or which is of such severity that the investigators deem it unwise to enter the research participant on protocol | 1 | [
"Research",
"participants",
"with",
"any",
"non-malignant",
"intercurrent",
"illness",
"which",
"is",
"either",
"poorly",
"controlled",
"with",
"currently",
"available",
"treatment",
",",
"or",
"which",
"is",
"of",
"such",
"severity",
"that",
"the",
"investigators",
"deem",
"it",
"unwise",
"to",
"enter",
"the",
"research",
"participant",
"on",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02207439 | 116:125:treatment | Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits | 1 | [
"Patients",
"must",
"sign",
"an",
"informed",
"consent",
"document",
"that",
"indicates",
"they",
"are",
"aware",
"of",
"the",
"investigational",
"nature",
"of",
"the",
"treatment",
"in",
"this",
"protocol",
"as",
"well",
"as",
"the",
"potential",
"risks",
"and",
"benefits"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02200445 | ,,,104:113:treatment, | Men and women of reproductive potential must agree to use an acceptable method of birth control during treatment and for six months after completion of treatment | 1 | [
"Men",
"and",
"women",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"an",
"acceptable",
"method",
"of",
"birth",
"control",
"during",
"treatment",
"and",
"for",
"six",
"months",
"after",
"completion",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02188121 | 62:71:treatment,,, | defined as entering one of the two-year First Episode Clinic treatment programs as a de novo patient (new disease) or having been diagnosed >2 years ago and had at least six visits in the past 12 months (prevalent disease) | 1 | [
"defined",
"as",
"entering",
"one",
"of",
"the",
"two-year",
"First",
"Episode",
"Clinic",
"treatment",
"programs",
"as",
"a",
"de",
"novo",
"patient",
"(",
"new",
"disease",
")",
"or",
"having",
"been",
"diagnosed",
">",
"2",
"years",
"ago",
"and",
"had",
"at",
"least",
"six",
"visits",
"in",
"the",
"past",
"12",
"months",
"(",
"prevalent",
"disease",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02184520 | 10:19:treatment | Requires treatment of more than two vertebral levels | 1 | [
"Requires",
"treatment",
"of",
"more",
"than",
"two",
"vertebral",
"levels"
] | [
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02181478 | 6:15:treatment | such treatment may continue until the planned course is completed | 1 | [
"such",
"treatment",
"may",
"continue",
"until",
"the",
"planned",
"course",
"is",
"completed"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02178709 | ,,,149:158:treatment | WOCBP and men must agree to use adequate contraception prior, to study entry, for the duration of study participation, and 8 weeks after the end of treatment | 1 | [
"WOCBP",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"prior",
",",
"to",
"study",
"entry",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"8",
"weeks",
"after",
"the",
"end",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02176967 | 58:67:treatment | Patients must meet the specified criteria for one of the treatment groups defined below; genomic features include MYCN gene amplification, segmental chromosome aberrations (somatic copy number loss at 1p, 3p, 4p, or 11q or somatic copy number gain at 1q, 2p, or 17q) and deoxyribonucleic acid (DNA) index | 1 | [
"Patients",
"must",
"meet",
"the",
"specified",
"criteria",
"for",
"one",
"of",
"the",
"treatment",
"groups",
"defined",
"below",
";",
"genomic",
"features",
"include",
"MYCN",
"gene",
"amplification",
",",
"segmental",
"chromosome",
"aberrations",
"(",
"somatic",
"copy",
"number",
"loss",
"at",
"1p",
",",
"3p",
",",
"4p",
",",
"or",
"11q",
"or",
"somatic",
"copy",
"number",
"gain",
"at",
"1q",
",",
"2p",
",",
"or",
"17q",
")",
"and",
"deoxyribonucleic",
"acid",
"(",
"DNA",
")",
"index"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02171104 | ,,,97:106:treatment | menstruating females must have a negative serum or urine pregnancy test within 14 days of study treatment start | 1 | [
"menstruating",
"females",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"within",
"14",
"days",
"of",
"study",
"treatment",
"start"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02166905 | 29:38:treatment | Have been informed of other treatment options | 1 | [
"Have",
"been",
"informed",
"of",
"other",
"treatment",
"options"
] | [
0,
0,
0,
0,
0,
1,
0
] |
NCT02166905 | ,,118:127:treatment | Patients of child-bearing potential must agree to use acceptable contraceptive methods (e.g., double barrier) during treatment | 1 | [
"Patients",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"acceptable",
"contraceptive",
"methods",
"(",
"e.g.",
",",
"double",
"barrier",
")",
"during",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02161211 | 11:20:treatment | inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence | 1 | [
"inpatient",
"treatment",
"at",
"Lodging",
"Plus",
"primarily",
"for",
"alcohol",
"(",
"vs.",
"other",
"drug",
")",
"dependence"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02159027 | 10:19:treatment | Adequate treatment is defined as meeting the current recommendations of the Centers of Disease Control and Prevention (CDC), National Institutes of Health (NIH) and the HIV Medicine Association of the Infectious Diseases Society of America (IDSA) guidelines33 | 1 | [
"Adequate",
"treatment",
"is",
"defined",
"as",
"meeting",
"the",
"current",
"recommendations",
"of",
"the",
"Centers",
"of",
"Disease",
"Control",
"and",
"Prevention",
"(",
"CDC",
")",
",",
"National",
"Institutes",
"of",
"Health",
"(",
"NIH",
")",
"and",
"the",
"HIV",
"Medicine",
"Association",
"of",
"the",
"Infectious",
"Diseases",
"Society",
"of",
"America",
"(",
"IDSA",
")",
"guidelines33"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02159027 | 123:132:treatment | non-heterosexually active or have a an exclusive vasectomized partner from screening throughout the duration of the study treatment | 1 | [
"non-heterosexually",
"active",
"or",
"have",
"a",
"an",
"exclusive",
"vasectomized",
"partner",
"from",
"screening",
"throughout",
"the",
"duration",
"of",
"the",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02158793 | 64:73:treatment | willing and able to return to follow-up visits as described in treatment plan | 1 | [
"willing",
"and",
"able",
"to",
"return",
"to",
"follow-up",
"visits",
"as",
"described",
"in",
"treatment",
"plan"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02158234 | ,,,143:152:treatment | Women of childbearing potential or sexually active males must be willing to use effective contraception throughout their participation in the treatment phase of the study | 1 | [
"Women",
"of",
"childbearing",
"potential",
"or",
"sexually",
"active",
"males",
"must",
"be",
"willing",
"to",
"use",
"effective",
"contraception",
"throughout",
"their",
"participation",
"in",
"the",
"treatment",
"phase",
"of",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02153229 | 101:110:treatment | Patients must sign a document that indicates that they are aware of the investigative nature of the treatment of this protocol, and the potential benefits and risks | 1 | [
"Patients",
"must",
"sign",
"a",
"document",
"that",
"indicates",
"that",
"they",
"are",
"aware",
"of",
"the",
"investigative",
"nature",
"of",
"the",
"treatment",
"of",
"this",
"protocol",
",",
"and",
"the",
"potential",
"benefits",
"and",
"risks"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02152995 | 11:20:treatment,, | All prior treatment-related toxicities must be Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v 4.0) grade =< 1 | 1 | [
"All",
"prior",
"treatment-related",
"toxicities",
"must",
"be",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"Events",
"version",
"4.0",
"(",
"CTCAE",
"v",
"4.0",
")",
"grade",
"=",
"<",
"1"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02143050 | ,,70:79:treatment, | Fertile males should use an effective method of contraception during treatment and for at least 3 months after completion of treatment, as directed by their physician | 1 | [
"Fertile",
"males",
"should",
"use",
"an",
"effective",
"method",
"of",
"contraception",
"during",
"treatment",
"and",
"for",
"at",
"least",
"3",
"months",
"after",
"completion",
"of",
"treatment",
",",
"as",
"directed",
"by",
"their",
"physician"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02140255 | 159:168:treatment | Otherwise assessed by the site investigator or designee, in consultation with the Clinical Management Committee (CMC), as having an indication to re-initiate treatment | 1 | [
"Otherwise",
"assessed",
"by",
"the",
"site",
"investigator",
"or",
"designee",
",",
"in",
"consultation",
"with",
"the",
"Clinical",
"Management",
"Committee",
"(",
"CMC",
")",
",",
"as",
"having",
"an",
"indication",
"to",
"re-initiate",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02135588 | ,,86:95:treatment | must have a negative urine or serum pregnancy test within 2 weeks prior to beginning treatment on this trial | 1 | [
"must",
"have",
"a",
"negative",
"urine",
"or",
"serum",
"pregnancy",
"test",
"within",
"2",
"weeks",
"prior",
"to",
"beginning",
"treatment",
"on",
"this",
"trial"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02133196 | ,,136:145:treatment | Patients of both genders must be willing to practice birth control from the time of enrollment on this study and for four months after treatment | 1 | [
"Patients",
"of",
"both",
"genders",
"must",
"be",
"willing",
"to",
"practice",
"birth",
"control",
"from",
"the",
"time",
"of",
"enrollment",
"on",
"this",
"study",
"and",
"for",
"four",
"months",
"after",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02132598 | ,69:78:treatment | Any of the following within 6 months before the first dose of study treatment | 1 | [
"Any",
"of",
"the",
"following",
"within",
"6",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02132598 | ,99:108:treatment | Patients must have normal organ and marrow function as defined below: (within 4 days of beginning treatment unless noted otherwise) | 1 | [
"Patients",
"must",
"have",
"normal",
"organ",
"and",
"marrow",
"function",
"as",
"defined",
"below",
":",
"(",
"within",
"4",
"days",
"of",
"beginning",
"treatment",
"unless",
"noted",
"otherwise",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02132598 | ,,,,191:200:treatment | The subject has prothrombin time (PT)/ International Normalized Ratio (INR) or partial thromboplastin time (PTT) test ≥ 1.3 x the laboratory ULN within 7 days before the first dose of study treatment | 1 | [
"The",
"subject",
"has",
"prothrombin",
"time",
"(",
"PT",
")",
"/",
"International",
"Normalized",
"Ratio",
"(",
"INR",
")",
"or",
"partial",
"thromboplastin",
"time",
"(",
"PTT",
")",
"test",
"≥",
"1.3",
"x",
"the",
"laboratory",
"ULN",
"within",
"7",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02128230 | 107:116:treatment | Patients must have signed an IRB-approved informed consent indicating their understanding of the proposed treatment and understanding that the protocol has been approved by the IRB | 1 | [
"Patients",
"must",
"have",
"signed",
"an",
"IRB-approved",
"informed",
"consent",
"indicating",
"their",
"understanding",
"of",
"the",
"proposed",
"treatment",
"and",
"understanding",
"that",
"the",
"protocol",
"has",
"been",
"approved",
"by",
"the",
"IRB"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02122081 | ,,,100:109:treatment | Fertile men and women unwilling to use contraceptive techniques during and for 12 months following treatment | 1 | [
"Fertile",
"men",
"and",
"women",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"12",
"months",
"following",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02122081 | 116:125:treatment,, | If the patient has an intra-abdominal chloroma on presentation, and has a partial response or complete response to treatment (size reduction of chloroma and marrow blast < 10%), the patient is eligible | 1 | [
"If",
"the",
"patient",
"has",
"an",
"intra-abdominal",
"chloroma",
"on",
"presentation",
",",
"and",
"has",
"a",
"partial",
"response",
"or",
"complete",
"response",
"to",
"treatment",
"(",
"size",
"reduction",
"of",
"chloroma",
"and",
"marrow",
"blast",
"<",
"10",
"%",
")",
",",
"the",
"patient",
"is",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02111850 | ,,142:151:treatment | Patients of both genders must be willing to practice birth control from the time of enrollment on this study and for up to four months after treatment | 1 | [
"Patients",
"of",
"both",
"genders",
"must",
"be",
"willing",
"to",
"practice",
"birth",
"control",
"from",
"the",
"time",
"of",
"enrollment",
"on",
"this",
"study",
"and",
"for",
"up",
"to",
"four",
"months",
"after",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02111850 | ,,122:131:treatment | Women of child-bearing potential must have a negative pregnancy test because of the potentially dangerous effects of the treatment on the fetus | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02111850 | ,,120:129:treatment | Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the treatment on the fetus or infant | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"who",
"are",
"pregnant",
"or",
"breastfeeding",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus",
"or",
"infant"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02108860 | ,,95:104:treatment | Both women and men must be willing to use an effective means of birth control while receiving treatment through this study | 1 | [
"Both",
"women",
"and",
"men",
"must",
"be",
"willing",
"to",
"use",
"an",
"effective",
"means",
"of",
"birth",
"control",
"while",
"receiving",
"treatment",
"through",
"this",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02108860 | 33:42:treatment | Willing and able to comply with treatment and follow-up procedures | 1 | [
"Willing",
"and",
"able",
"to",
"comply",
"with",
"treatment",
"and",
"follow-up",
"procedures"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02106650 | ,,80:89:treatment, | Male patients are to agree to use a barrier method of contraception from study treatment initiation until at least 90 days after the last administration of Folotyn | 1 | [
"Male",
"patients",
"are",
"to",
"agree",
"to",
"use",
"a",
"barrier",
"method",
"of",
"contraception",
"from",
"study",
"treatment",
"initiation",
"until",
"at",
"least",
"90",
"days",
"after",
"the",
"last",
"administration",
"of",
"Folotyn"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02102113 | 21:30:treatment | Current or lifetime treatment | 1 | [
"Current",
"or",
"lifetime",
"treatment"
] | [
0,
0,
0,
1
] |
NCT02101736 | ,,,98:107:treatment | Hemoptysis of ≥0.5 teaspoon (2.5 mL) of red blood within 3 months before the first dose of study treatment | 1 | [
"Hemoptysis",
"of",
"≥0.5",
"teaspoon",
"(",
"2.5",
"mL",
")",
"of",
"red",
"blood",
"within",
"3",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02101034 | ,,,187:196:treatment | Female patients must be surgically sterile or be postmenopausal, or must agree to use effective contraceptive during the period of the trial and for at least 90 days after completion of treatment | 1 | [
"Female",
"patients",
"must",
"be",
"surgically",
"sterile",
"or",
"be",
"postmenopausal",
",",
"or",
"must",
"agree",
"to",
"use",
"effective",
"contraceptive",
"during",
"the",
"period",
"of",
"the",
"trial",
"and",
"for",
"at",
"least",
"90",
"days",
"after",
"completion",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02100891 | ,,,110:119:treatment, | Fertile females who are unwilling to use contraceptive techniques during and for the twelve months following treatment, as well as females who are pregnant or actively breast feeding | 1 | [
"Fertile",
"females",
"who",
"are",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"the",
"twelve",
"months",
"following",
"treatment",
",",
"as",
"well",
"as",
"females",
"who",
"are",
"pregnant",
"or",
"actively",
"breast",
"feeding"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02100891 | ,,,108:117:treatment | Fertile males who are unwilling to use contraceptive techniques during and for the twelve months following treatment | 1 | [
"Fertile",
"males",
"who",
"are",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"the",
"twelve",
"months",
"following",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02100891 | 86:95:treatment | Patients, who in the opinion of the investigator, may not be able to comply with the treatment plan or safety monitoring requirements of the study Page 16 of 86 Children's Hospital of Wisconsin Medical College of Wisconsin | 1 | [
"Patients",
",",
"who",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"may",
"not",
"be",
"able",
"to",
"comply",
"with",
"the",
"treatment",
"plan",
"or",
"safety",
"monitoring",
"requirements",
"of",
"the",
"study",
"Page",
"16",
"of",
"86",
"Children",
"'s",
"Hospital",
"of",
"Wisconsin",
"Medical",
"College",
"of",
"Wisconsin"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02099058 | ,,,113:122:treatment | Women of childbearing potential must have a negative serum pregnancy test within 14 days prior to initiation of treatment | 1 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"within",
"14",
"days",
"prior",
"to",
"initiation",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02098161 | 198:207:treatment | Any concurrent severe and/or uncontrolled medical conditions that could increase the patient's risk for toxicity while in the study or that could confound discrimination between disease- and study treatment-related toxicities | 1 | [
"Any",
"concurrent",
"severe",
"and/or",
"uncontrolled",
"medical",
"conditions",
"that",
"could",
"increase",
"the",
"patient",
"'s",
"risk",
"for",
"toxicity",
"while",
"in",
"the",
"study",
"or",
"that",
"could",
"confound",
"discrimination",
"between",
"disease-",
"and",
"study",
"treatment-related",
"toxicities"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02098161 | 51:60:treatment | Willing and able to comply with scheduled visits, treatment plan and laboratory tests | 1 | [
"Willing",
"and",
"able",
"to",
"comply",
"with",
"scheduled",
"visits",
",",
"treatment",
"plan",
"and",
"laboratory",
"tests"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02094794 | ,,149:158:treatment | The time from the end last induction, re-induction, or consolidation regimen should be greater than or equal to 14 days from planned start of study treatment | 1 | [
"The",
"time",
"from",
"the",
"end",
"last",
"induction",
",",
"re-induction",
",",
"or",
"consolidation",
"regimen",
"should",
"be",
"greater",
"than",
"or",
"equal",
"to",
"14",
"days",
"from",
"planned",
"start",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02080221 | ,,,,,178:187:treatment | Women of child bearing potential must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 7 days prior to beginning of treatment | 1 | [
"Women",
"of",
"child",
"bearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"(",
"minimum",
"sensitivity",
"25",
"IU/L",
"or",
"equivalent",
"units",
"of",
"HCG",
")",
"within",
"7",
"days",
"prior",
"to",
"beginning",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02075671 | ,,,,,,257:266:treatment | They will also be required to be on at least one reliable form of effective birth control [examples: barrier method (condoms, diaphragm), oral, injectable, implant birth control or abstinence] during the course of this study and 30 days following the last treatment period | 1 | [
"They",
"will",
"also",
"be",
"required",
"to",
"be",
"on",
"at",
"least",
"one",
"reliable",
"form",
"of",
"effective",
"birth",
"control",
"[",
"examples",
":",
"barrier",
"method",
"(",
"condoms",
",",
"diaphragm",
")",
",",
"oral",
",",
"injectable",
",",
"implant",
"birth",
"control",
"or",
"abstinence",
"]",
"during",
"the",
"course",
"of",
"this",
"study",
"and",
"30",
"days",
"following",
"the",
"last",
"treatment",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02072356 | ,,117:126:treatment | Evidence of potential delivery of greater than 16.5 mCi (30 Gy absorbed dose) of radiation to the lungs in a single treatment | 1 | [
"Evidence",
"of",
"potential",
"delivery",
"of",
"greater",
"than",
"16.5",
"mCi",
"(",
"30",
"Gy",
"absorbed",
"dose",
")",
"of",
"radiation",
"to",
"the",
"lungs",
"in",
"a",
"single",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02059239 | ,,,,128:137:treatment | Male and female subjects must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment | 1 | [
"Male",
"and",
"female",
"subjects",
"must",
"use",
"an",
"effective",
"contraceptive",
"method",
"during",
"the",
"study",
"and",
"for",
"a",
"minimum",
"of",
"6",
"months",
"after",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02056873 | 41:50:treatment | (If the subject chooses not to have the treatment, they cannot participate in the study | 1 | [
"(",
"If",
"the",
"subject",
"chooses",
"not",
"to",
"have",
"the",
"treatment",
",",
"they",
"can",
"not",
"participate",
"in",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02055053 | 36:45:treatment | History of Chronic pain or ongoing treatment for chronic pain | 1 | [
"History",
"of",
"Chronic",
"pain",
"or",
"ongoing",
"treatment",
"for",
"chronic",
"pain"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02048371 | 76:85:treatment | Patients who progress on placebo are specifically allowed to enroll on the treatment arm of the study if they meet all other entry criteria | 1 | [
"Patients",
"who",
"progress",
"on",
"placebo",
"are",
"specifically",
"allowed",
"to",
"enroll",
"on",
"the",
"treatment",
"arm",
"of",
"the",
"study",
"if",
"they",
"meet",
"all",
"other",
"entry",
"criteria"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02048371 | 24:33:treatment | Previous assignment to treatment during this study | 1 | [
"Previous",
"assignment",
"to",
"treatment",
"during",
"this",
"study"
] | [
0,
0,
0,
1,
0,
0,
0
] |
NCT02043548 | ,,,104:113:treatment, | Men and women of reproductive potential must agree to use an acceptable method of birth control during treatment and for twelve months after completion of treatment | 1 | [
"Men",
"and",
"women",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"an",
"acceptable",
"method",
"of",
"birth",
"control",
"during",
"treatment",
"and",
"for",
"twelve",
"months",
"after",
"completion",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02020707 | ,,74:83:treatment | Willing to return to enrolling institution for follow-up 2-4 weeks after treatment discontinuation | 1 | [
"Willing",
"to",
"return",
"to",
"enrolling",
"institution",
"for",
"follow-up",
"2-4",
"weeks",
"after",
"treatment",
"discontinuation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02016924 | ,,111:120:treatment | females of childbearing potential must agree to utilize highly effective contraception methods while on study treatment or agree to abstain from heterosexual intercourse throughout the study period | 1 | [
"females",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"utilize",
"highly",
"effective",
"contraception",
"methods",
"while",
"on",
"study",
"treatment",
"or",
"agree",
"to",
"abstain",
"from",
"heterosexual",
"intercourse",
"throughout",
"the",
"study",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02013778 | 37:46:treatment | Participation in another concurrent treatment protocol | 1 | [
"Participation",
"in",
"another",
"concurrent",
"treatment",
"protocol"
] | [
0,
0,
0,
0,
1,
0
] |
NCT02004275 | ,65:74:treatment | Must agree to not become pregnant or breast feed a child during treatment on this protocol | 1 | [
"Must",
"agree",
"to",
"not",
"become",
"pregnant",
"or",
"breast",
"feed",
"a",
"child",
"during",
"treatment",
"on",
"this",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02004275 | 65:74:treatment | Previous hypersensitivity to any of the components of the study treatment | 1 | [
"Previous",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01993719 | ,,142:151:treatment | Patients of both genders must be willing to practice birth control from the time of enrollment on this study and for up to four months after treatment | 1 | [
"Patients",
"of",
"both",
"genders",
"must",
"be",
"willing",
"to",
"practice",
"birth",
"control",
"from",
"the",
"time",
"of",
"enrollment",
"on",
"this",
"study",
"and",
"for",
"up",
"to",
"four",
"months",
"after",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01993719 | ,,122:131:treatment | Women of child-bearing potential must have a negative pregnancy test because of the potentially dangerous effects of the treatment on the fetus | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01993719 | ,,120:129:treatment | Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the treatment on the fetus or infant | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"who",
"are",
"pregnant",
"or",
"breastfeeding",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus",
"or",
"infant"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01990209 | ,,,163:172:treatment, | Male patients (even those post vasectomy) who are willing to use adequate contraceptive measures or abstain from heterosexual intercourse during the entire study treatment period and for 4 months after the last dose of study drug | 1 | [
"Male",
"patients",
"(",
"even",
"those",
"post",
"vasectomy",
")",
"who",
"are",
"willing",
"to",
"use",
"adequate",
"contraceptive",
"measures",
"or",
"abstain",
"from",
"heterosexual",
"intercourse",
"during",
"the",
"entire",
"study",
"treatment",
"period",
"and",
"for",
"4",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01989546 | 81:90:treatment | for the duration of study participation, and for 30 days after completing study treatment | 1 | [
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"30",
"days",
"after",
"completing",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01983462 | 84:93:treatment | Any condition that, in the view of the PI, places the subject at high risk of poor treatment compliance or of not completing the study | 1 | [
"Any",
"condition",
"that",
",",
"in",
"the",
"view",
"of",
"the",
"PI",
",",
"places",
"the",
"subject",
"at",
"high",
"risk",
"of",
"poor",
"treatment",
"compliance",
"or",
"of",
"not",
"completing",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01976585 | 25:34:treatment | Able to comply with the treatment schedule | 1 | [
"Able",
"to",
"comply",
"with",
"the",
"treatment",
"schedule"
] | [
0,
0,
0,
0,
0,
1,
0
] |
NCT01972919 | 35:44:treatment | Participation in another clinical treatment trial while on study | 1 | [
"Participation",
"in",
"another",
"clinical",
"treatment",
"trial",
"while",
"on",
"study"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01967823 | ,,136:145:treatment | Patients of both genders must be willing to practice birth control from the time of enrollment on this study and for four months after treatment | 1 | [
"Patients",
"of",
"both",
"genders",
"must",
"be",
"willing",
"to",
"practice",
"birth",
"control",
"from",
"the",
"time",
"of",
"enrollment",
"on",
"this",
"study",
"and",
"for",
"four",
"months",
"after",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01967823 | ,,122:131:treatment | Women of child-bearing potential must have a negative pregnancy test because of the potentially dangerous effects of the treatment on the fetus | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01967823 | ,,120:129:treatment | Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the treatment on the fetus or infant | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"who",
"are",
"pregnant",
"or",
"breastfeeding",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus",
"or",
"infant"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01966367 | 30:39:treatment | Approval for the use of this treatment protocol by the individual institution's Human Rights Committee must be obtained, in accordance with the institutional assurance policies of the U. S. Department of Health and Human Services | 1 | [
"Approval",
"for",
"the",
"use",
"of",
"this",
"treatment",
"protocol",
"by",
"the",
"individual",
"institution",
"'s",
"Human",
"Rights",
"Committee",
"must",
"be",
"obtained",
",",
"in",
"accordance",
"with",
"the",
"institutional",
"assurance",
"policies",
"of",
"the",
"U.",
"S.",
"Department",
"of",
"Health",
"and",
"Human",
"Services"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01959698 | ,,157:166:treatment | HBV DNA is negative, the subject may be included but must undergo at least every 2 months HBV DNA polymerase chain reaction (PCR) testing from the start of treatment throughout the duration the treatment course | 1 | [
"HBV",
"DNA",
"is",
"negative",
",",
"the",
"subject",
"may",
"be",
"included",
"but",
"must",
"undergo",
"at",
"least",
"every",
"2",
"months",
"HBV",
"DNA",
"polymerase",
"chain",
"reaction",
"(",
"PCR",
")",
"testing",
"from",
"the",
"start",
"of",
"treatment",
"throughout",
"the",
"duration",
"the",
"treatment",
"course"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01959698 | ,,,,,125:134:treatment | Serum creatinine of =< 1.5 mg/dL; if creatinine > 1.5 mg/dL creatinine clearance must be > 60 mL/min within 7 days prior to treatment either measured or calculated using a standard Cockcroft and Gault formula | 1 | [
"Serum",
"creatinine",
"of",
"=",
"<",
"1.5",
"mg/dL",
";",
"if",
"creatinine",
">",
"1.5",
"mg/dL",
"creatinine",
"clearance",
"must",
"be",
">",
"60",
"mL/min",
"within",
"7",
"days",
"prior",
"to",
"treatment",
"either",
"measured",
"or",
"calculated",
"using",
"a",
"standard",
"Cockcroft",
"and",
"Gault",
"formula"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851 | ,73:82:treatment | at least 28 days (whichever is longer) following the last dose of study treatment | 1 | [
"at",
"least",
"28",
"days",
"(",
"whichever",
"is",
"longer",
")",
"following",
"the",
"last",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01920737 | ,,113:122:treatment, | Men and women of childbearing potential must be willing to practice an effective method of birth control during treatment and at least 4 months after treatment is finished | 1 | [
"Men",
"and",
"women",
"of",
"childbearing",
"potential",
"must",
"be",
"willing",
"to",
"practice",
"an",
"effective",
"method",
"of",
"birth",
"control",
"during",
"treatment",
"and",
"at",
"least",
"4",
"months",
"after",
"treatment",
"is",
"finished"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01896999 | ,,113:122:treatment | vaccines are not prohibited on study, but must be given at least 6 weeks after cycle 1 and not within 7 days of treatment | 1 | [
"vaccines",
"are",
"not",
"prohibited",
"on",
"study",
",",
"but",
"must",
"be",
"given",
"at",
"least",
"6",
"weeks",
"after",
"cycle",
"1",
"and",
"not",
"within",
"7",
"days",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01893554 | 75:84:treatment | Subjects with clinically insignificant cardiac abnormalities requiring no treatment may be enrolled | 1 | [
"Subjects",
"with",
"clinically",
"insignificant",
"cardiac",
"abnormalities",
"requiring",
"no",
"treatment",
"may",
"be",
"enrolled"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01884740 | ,,,144:153:treatment | Patients of reproductive age must agree to use a medically effective method of contraception during and for a period of three months after the treatment period | 1 | [
"Patients",
"of",
"reproductive",
"age",
"must",
"agree",
"to",
"use",
"a",
"medically",
"effective",
"method",
"of",
"contraception",
"during",
"and",
"for",
"a",
"period",
"of",
"three",
"months",
"after",
"the",
"treatment",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01877382 | 23:32:treatment | for which no standard treatment is available | 1 | [
"for",
"which",
"no",
"standard",
"treatment",
"is",
"available"
] | [
0,
0,
0,
0,
1,
0,
0
] |
NCT01877382 | 1:10:treatment, | treatment with small-molecule targeted agents within 2 weeks before study drug treatment | 1 | [
"treatment",
"with",
"small-molecule",
"targeted",
"agents",
"within",
"2",
"weeks",
"before",
"study",
"drug",
"treatment"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01873131 | 46:55:treatment | Willingness of parent/guardian to follow the treatment schedule and post treatment care requirements | 1 | [
"Willingness",
"of",
"parent/guardian",
"to",
"follow",
"the",
"treatment",
"schedule",
"and",
"post",
"treatment",
"care",
"requirements"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01873131 | 56:65:treatment | Willingness of parent/guardian to receive EXPERIMENTAL treatment | 1 | [
"Willingness",
"of",
"parent/guardian",
"to",
"receive",
"EXPERIMENTAL",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT01873131 | 48:57:treatment | whose parent/guardian is unable to comply with treatment, home care or follow-up visits | 1 | [
"whose",
"parent/guardian",
"is",
"unable",
"to",
"comply",
"with",
"treatment",
",",
"home",
"care",
"or",
"follow-up",
"visits"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01871766 | ,,,,,,143:152:treatment | Female participants ≥ 10 years of age or post-menarchal must have a negative serum or urine pregnancy test within 24 hours prior to beginning treatment | 1 | [
"Female",
"participants",
"≥",
"10",
"years",
"of",
"age",
"or",
"post-menarchal",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"within",
"24",
"hours",
"prior",
"to",
"beginning",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01869114 | 96:105:treatment | Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing | 1 | [
"Patients",
"must",
"be",
"able",
"to",
"sign",
"consent",
"and",
"be",
"willing",
"and",
"able",
"to",
"comply",
"with",
"scheduled",
"visits",
",",
"treatment",
"plan",
"and",
"laboratory",
"testing"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01861106 | 174:183:treatment | Should a patient have progressive disease, or a donor becomes not available after enrollment, the patient will be referred back to their primary hematologist-oncologist for treatment | 1 | [
"Should",
"a",
"patient",
"have",
"progressive",
"disease",
",",
"or",
"a",
"donor",
"becomes",
"not",
"available",
"after",
"enrollment",
",",
"the",
"patient",
"will",
"be",
"referred",
"back",
"to",
"their",
"primary",
"hematologist-oncologist",
"for",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01841333 | ,,,138:147:treatment | Serum/urine pregnancy test (for females of childbearing potential) that is negative within 72 hours prior to initiation of first dose of treatment | 1 | [
"Serum/urine",
"pregnancy",
"test",
"(",
"for",
"females",
"of",
"childbearing",
"potential",
")",
"that",
"is",
"negative",
"within",
"72",
"hours",
"prior",
"to",
"initiation",
"of",
"first",
"dose",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01829958 | 38:47:treatment | Must meet criteria for initiation of treatment | 1 | [
"Must",
"meet",
"criteria",
"for",
"initiation",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
1
] |